OcuNexus Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:OcuNexus Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10810
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OcuNexus Therapeutics Inc (OcuNexus Therapeutics) is a development stage biopharmaceutical company engaged in novel therapeutics for unmet clinical needs in ophthalmology. It has highly differentiated, lead drug candidates based upon a novel mechanism of action such as Gap Junction Channel Modulation. The company’s product pipeline comprises of proprietary connexin hemichannel modulators such as Nexagon, Peptagon and HCB1019 with distinct modes of action in topical, systemic, intravitreal and oral administration. Its fundamental modulation technology has been shown work in a variety of tissue types including, eye, skin, brain, nerve, and spinal cord. OcuNexus is headquartered in San Diego, California, the US.

OcuNexus Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
OcuNexus Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
CoDa Therapeutics Raises USD0.8 Million Financing 11
CoDa Therapeutics Raises USD1.2 Million in Venture Financing 12
CoDa Therapeutics Raises USD1 Million in Venture Financing 13
CoDa Therapeutics Raises USD2.5 Million in Venture Financing 14
CoDa Therapeutics Raises Additional US$20 Million In Series B Financing 15
Licensing Agreements 17
Eyevance Pharma Enters into Licensing Agreement with OcuNexus Therapeutics 17
OcuNexus Therapeutics Inc – Key Competitors 18
OcuNexus Therapeutics Inc – Key Employees 19
OcuNexus Therapeutics Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Jan 02, 2018: Ocunexus Therapeutics appoints Dr. Brian Levy as CEO 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OcuNexus Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
OcuNexus Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CoDa Therapeutics Raises USD0.8 Million Financing 11
CoDa Therapeutics Raises USD1.2 Million in Venture Financing 12
CoDa Therapeutics Raises USD1 Million in Venture Financing 13
CoDa Therapeutics Raises USD2.5 Million in Venture Financing 14
CoDa Therapeutics Raises Additional US$20 Million In Series B Financing 15
Eyevance Pharma Enters into Licensing Agreement with OcuNexus Therapeutics 17
OcuNexus Therapeutics Inc, Key Competitors 18
OcuNexus Therapeutics Inc, Key Employees 19

List of Figures
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
OcuNexus Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[OcuNexus Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sygnity SA (SGN):企業の財務・戦略的SWOT分析
    Sygnity SA (SGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Civica Group Limited:企業の戦略的SWOT分析
    Civica Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • OsteoVantage Inc:製品パイプライン分析
    Summary OsteoVantage Inc (OsteoVantage) is a medical device company that develops osteogenic spinal instrumentation technology used in spinal fusion procedures. The company’s INDOS system is an osteogenic spinal instrumentation for use in lumbar spinal fusion procedures. It also offers osteomodulati …
  • BKW AG:企業の戦略・SWOT・財務情報
    BKW AG - Strategy, SWOT and Corporate Finance Report Summary BKW AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Laboratorio Reig Jofre SA (RJF):製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratorio Reig Jofre SA (Reig Jofre) is a pharmaceutical company that researches, develops, manufactures and markets medicinal products and nutritional supplements. The company’s product categories include specialized technology products, specialty therapeutic areas, and consumer healthcar …
  • Oil Search Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Oil Search Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Oil Search Ltd (Oil Search) is an independent upstream energy company. It explores for, develops and produces oil, natural gas and natural gas liquids (NGL). The company has majority of its oil and ga …
  • BrainScope Company Inc:医療機器:M&Aディール及び事業提携情報
    Summary BrainScope Company Inc (BrainScope) is a medical device company that offers medical neurotechnology products. The company develops and distributes non-invasive instruments for the treatment of traumatic brain injuries, moderate traumatic brain injury and mild traumatic brain injury. It provi …
  • Compuware Corp:企業の戦略・SWOT・財務分析
    Compuware Corp - Strategy, SWOT and Corporate Finance Report Summary Compuware Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Tata Steel Europe Ltd:企業の戦略・SWOT・財務情報
    Tata Steel Europe Ltd - Strategy, SWOT and Corporate Finance Report Summary Tata Steel Europe Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Boditech Med Inc (206640):企業の製品パイプライン分析2018
    Summary Boditech Med Inc (Boditech) is a medical device company that manufactures and distributes in-vitro diagnostic analyzers and reagents. The company’s products include ichroma Reader, a portable fluorescence scanning instrument and AFIAS-6, a next-generation fluorescence processing and scanning …
  • First Quantum Minerals Ltd:戦略・SWOT・企業財務分析
    First Quantum Minerals Ltd - Strategy, SWOT and Corporate Finance Report Summary First Quantum Minerals Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Laing O’Rourke Plc:企業の戦略的SWOT分析
    Laing O'Rourke Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Ontario Power Generation Inc:電力:M&Aディール及び事業提携情報
    Summary Ontario Power Generation Inc (OPG) is an electric utility. It generates and sells energy. The company produces power from nuclear, hydro, and thermal sources. OPG has long-term lease arrangement and related agreements with Bruce Power related to the Bruce nuclear generating stations. It also …
  • Indigo Books & Music Inc:企業の戦略・SWOT・財務分析
    Indigo Books & Music Inc - Strategy, SWOT and Corporate Finance Report Summary Indigo Books & Music Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Virgin Australia Holdings Ltd:企業の戦略・SWOT・財務分析
    Virgin Australia Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Virgin Australia Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Living Proof Inc-製薬・医療分野:企業M&A・提携分析
    Summary Living Proof Inc (Living Proof) is a healthcare products provider that offers hair care products. The company offers hair travel kits, dry shampoos, hair conditioner, styling treatment kits, night cap overnight perfector, pre shampoo treatment, timeless shampoo, plumping mousse, nourishing s …
  • Japan Tobacco Inc (2914):製薬・医療:M&Aディール及び事業提携情報
    Summary Japan Tobacco Inc (JT Group) is a tobacco company that primarily manufactures cigarettes. It also manufactures, markets and sells varied pharmaceutical and processed food products such as frozen cooked rice and noodles, instant noodles, bread and frozen bread, mineral water, and seasoning, p …
  • IES Holdings, Inc.:企業の戦略・SWOT・財務情報
    IES Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary IES Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Trimble Solutions Oy:企業の戦略的SWOT分析
    Trimble Solutions Oy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Olin Corporation:企業の戦略・SWOT・財務情報
    Olin Corporation - Strategy, SWOT and Corporate Finance Report Summary Olin Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆